AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer patients. The system, which was already FDA-cleared for the surgical ...

AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target and destroy tissue without delivering excess heat and the unintended ...

Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...

George was the youngest person to be treated for cancer with Nanoknife technology - also known as irreversible ...

European Union: The NanoKnife System is indicated for the ablation of prostate tissue in patients with intermediate risk prostate cancer. About AngioDynamics, Inc. AngioDynamics is a leading and ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

George was the youngest person to be treated for cancer with Nanoknife technology - also known as irreversible electroporation A two-year-old boy from north London who was the youngest person to ...

A two-year-old boy from north London who was the youngest person to be treated for cancer with Nanoknife technology is now cancer-free. George, from Camden, was diagnosed with rhabdomyosarcoma ...